# Duration of ANtibiotic Therapy for CEllulitis

> **NCT02032654** · PHASE4 · TERMINATED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 151 (actual)

## Conditions studied

- Cellulitis
- Erysipelas

## Interventions

- **DRUG:** Flucloxacillin
- **DRUG:** Placebo (for flucloxacillin)

## Key facts

- **NCT ID:** NCT02032654
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-08-26
- **Primary completion:** 2017-07-24
- **Final completion:** 2017-09-25
- **Target enrollment:** 151 (ACTUAL)
- **Why stopped:** Budget exceeded
- **Last updated:** 2017-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02032654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02032654, "Duration of ANtibiotic Therapy for CEllulitis". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02032654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*